Company / Financials
Moderna Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.9B
FY2025 · -39.9% YoY
Net Income
-$2.8B
FY2025 · +20.8% YoY
Profit Margin
-145.2%
FY2025 · net income / revenue
ROE
-32.6%
FY2025 · return on equity
Total Assets
$12.3B
FY2025
Total Debt
$590.0M
0.07x debt/equity
Equity
$8.7B
FY2025
ROA
-22.9%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.9B-39.9% YoYNet Income HistoryProfit after all expenses and taxes-$2.8B+20.8% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$868.0M-40.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$3.1B+22.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$1.0B-13.3% YoYR&D Expense HistoryResearch and development spending$3.1B-31.1% YoYIncome Tax HistoryTotal income tax expense$54.0M+217.4% YoYEPS (Basic) HistoryBasic earnings per share-$12.33-158.0% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$12.33-161.3% YoYShares Outstanding HistoryWeighted average diluted shares outstanding386.0M+1.0% YoY